Moreover, both PGC1α and PPARγ are similarly upregulated and palmitate constituent was increased in the liver in the NAFLD mouse model, indicating a positive correlation with the triglyceride content. The gene discussed is PPARG; the disease is metabolic dysfunction-associated steatotic liver disease.